Michael Mee

[Michael Mee @miketmee]

Pleased that our portfolio company, @Valence Discovery, was acquired by Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX)

This is a testament to the founders’, @_danielcohen and @Therence_mtl , mission to build a world-leading generative AI small molecule design platform

[Valence Labs @valence_ai]

We are incredibly excited to integrate our powerful chemistry engine into @RecursionPharma’s OS to enable the future of AI-first drug discovery!

We’ll be expanding our ML research team at @Mila_Quebec with the aim of solving the hardest problems in drug discovery

Stay tuned!

[Valence Labs @valence_ai]

We are incredibly excited to integrate our powerful chemistry engine into @RecursionPharma’s OS to enable the future of AI-first drug discovery!

We’ll be expanding our ML research team at @Mila_Quebec with the aim of solving the hardest problems in drug discovery

Stay tuned!

[Valence Labs @valence_ai]

We are thrilled to be adding decades of drug discovery expertise to the Valence leadership team as we embark on these exciting next steps in our journey.

Please find more information here: https://t.co/Rk80PJmUkp

[Stem Cell Network @StemCellNetwork]

#ICYMI: The video from today’s information session for the Amplitude Ventures Fellowship Program, co-hosted by SCN, is now available. Watch it here: https://t.co/to6UQ4yrar
@amplitudeVC

[Medicine by Design @MbD_CCRM]

A great opportunity for trainees interested in entrepreneurship ⬇️

[Michael Mee @miketmee]

Happy to reveal one of our most exciting stealth companies! We're excited to get the Clementia team back together again and bring better therapies for rare diseases faster.

[Sean Silcoff @SeanSilcoff]

Congruence, led by Montreal biotech star Clarissa Desjardins raises $50-million to develop rare disease drugs /via @globeandmail https://t.co/RC0j50AC6n

[Jason Burch @DrBanjoCrush]

Great news from our neighbours at Congruence Therapeutics… more great news for the Montreal biotech scene.

[adMare BioInnovations @adMare_Bio]

Fantastic to see this innovative program from our partners at @amplitudeVC -- simultaneously building Canadian companies and Canadian talent -- two of adMare's key pillars. Make sure to get your applications in before their March 30th deadline!

[Michael Mee @miketmee]

NOW RECRUITING! The application deadline for the 2022 Amplitude Ventures Fellowship Program is March 30th. Are you an outstanding life science focused PhD candidate, post doc, MD, or inventor? The Amplitude Fellowship may be what you’re looking for.
https://t.co/BbVzUwLdXd

[Allyson Tighe @AllysonTighe]

Thrilled to announce our investment in ⁦@Gandeeva_Tx⁩! We have loved working with ⁦@cryoem_UBC⁩ and the team so far and we’re excited to build something incredible together. https://t.co/m71V9j19OY

[Jason Sheltzer @JSheltzer]

MIT has announced the launch of the Angelika Amon Young Scientist Award, a prize for PhD students at non-US institutions who are tackling unique research questions and have an infectious enthusiasm for discovery science!

Apply here -> https://t.co/phQ0TY1yNO

[Michael Mee @miketmee]

Excited to announce our latest investment! Giiant Pharma Inc Announced the Closing of US$11m in Seed Financing to Develop Its Precision Delivery Technology Platform in Gastroenterology https://t.co/m2F2dDzTi5

[Lloyd M. Segal @LM_Segal]

After years in stealth, finally introducing RP-6306 next week: a novel target and compound for patients with CCNE1 amplified and other tumors. Excited to share the breakthrough work of @RepareRx team as we prepare to enter clinical trials next Q! #precisiononcology #Cancer

[Michael Mee @miketmee]

If you are curious or want to learn more please sign up here https://t.co/q1AOr71n2c for one of our information sessions in the weeks ahead.

[Michael Mee @miketmee]

Calling all entrepreneurial life science PhDs, PostDocs and MDs! Amplitude Ventures is launching a summer fellowship program focused on building game-changing healthcare and therapeutic platform companies.

[Michael Mee @miketmee]

The program will run virtually from June - August 2021 and applications are due by April 30th. If you are training in Canada or a Canadian training abroad take a look at the details on our program below and apply.

[Michael Mee @miketmee]

If you are curious or want to learn more please sign up here https://t.co/q1AOr71n2c for one of our information sessions in the weeks ahead.

[Michael Mee @miketmee]

The program will run virtually from June - August 2021 and applications are due by April 30th. If you are training in Canada or a Canadian training abroad take a look at the details on our program below and apply at [email protected]

[EFFERVESCENCE MTL @EffervescenceV]

Good luck to the 10 finalists of the Startups Pitch Contest at #EFFERVESCENCEMTL.
@perceiv_ai, @vitaltracer, Statera Medical Inc., Jenthera Therapeutics Inc., Cura Therapeutics, @ModelisLabs, Anasens, PLAKK Inc., @elidothealth and GynAware.